百奥赛图预计2024年净利润2000万元至4000万元
财中社1月27日电百奥赛图-B（02315）发布公告，预计截至2024年12月31日止年度的营业收入约为9.69亿元至9.89亿元，较截至2023年12月31日止年度的营业收入约为7.17亿元，同比增加约35.2%至38%。同时，预计净利润将为2000万元至4000万元，而截至2023年12月31日止年度则出现了约3.83亿元的亏损。
公告中提到，预计研发费用约为3.12亿元至3.32亿元，较截至2023年12月31日止年度的研发费用约4.74亿元，同比减少约30.1%至34.3%。董事会指出，业绩改善主要归因于抗体发现业务获得更多海外客户认可，基因编辑动物模型业务快速增长，以及战略调整带来的研发投入下降和成本管控成效。
（文章来源：财中社）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10